Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietic Response to PEG-IFN/RBV in HCV/HIV Co-infection
NCT00315432Phase 2Completed
- Sponsor
- Ortho Biotech Inc.
- Start
- Sep 2000
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of pegylated interferon alpha, ribavirin in hepatitis C (HCV), sponsored by Ortho Biotech Inc.. Started Sep 2000; status: completed.
02
Drugs
pegylated interferon alpharibavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00315432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315432.